Physician profile

Carlos E Campo

Pulmonary Disease · Tallahassee, FL

NPI 1912922071

$87,201.69

in general payments reported to CMS, 2019-2025

49 companies · $6,428 in 2025

The $6,428 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$12,705.00
Travel and Lodging$6,348.07
Food and Beverage$6,053.88

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $59,927.63 2019-2025 Ofev, Jascayd
Janssen Pharmaceuticals, INC $9,905.87 2019-2021
Medical Device Business Services, INC. $3,129.78 2023-2024 Monarch, Na
Abiomed $2,851.11 2023-2025 Impella
Portola Pharmaceuticals, LLC $2,411.44 2019-2020
Astrazeneca Pharmaceuticals Lp $1,733.52 2021-2024 Andexxa, Breztri, Fasenra
Ethicon INC. $994.45 2022-2025 Monarch Platform
Veran Medical Technologies, INC. $686.03 2019-2020
Inari Medical, INC. $555.07 2022-2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Galvanize Therapeutics, INC $536.13 2025 Aliya System
Intuitive Surgical, INC. $494.10 2025
Actelion Pharmaceuticals US, INC. $455.21 2021-2025 Opsumit, Opsynvi, Uptravi
Pulmonx Corporation $406.78 2024-2025 Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter
Insmed, INC. $333.89 2019-2025 Arikayce, Brinsupri
Electromed, INC. $322.83 2019-2025 Smartvest
Show all 49 companies
CompanyGeneral paymentsYearsTop products
United Therapeutics Corporation $275.38 2019-2022
Medtronic, INC. $236.17 2021-2025 Symplicity G3
Glaxosmithkline, LLC. $216.45 2019
Ethicon US, LLC $176.00 2022
Harmony Biosciences LLC $162.04 2022-2025
Stryker Corporation $160.50 2025 Flowtriever
Genzyme Corporation $155.53 2022-2025
Alexion Pharmaceuticals, INC. $136.55 2021-2022
Genentech USA, INC. $123.26 2019-2020
Jazz Pharmaceuticals INC. $87.26 2021-2024
Merck Sharp & Dohme LLC $68.19 2019-2023 Keytruda
Covidien Lp $64.11 2019
Amgen INC. $59.09 2025 Tezspire
Mylan Specialty L.P. $53.72 2019-2024 Yupelri
Baxter Healthcare $49.22 2025 Hillrom - Vest System Model 105 Home Care
Verona Pharma, INC. $45.81 2025 Ohtuvayre
Philips North America LLC $44.55 2019
Viatris Specialty LLC $41.27 2025 Yupelri
Regeneron Healthcare Solutions, INC. $32.63 2023-2024 Dupixent
Mallinckrodt Hospital Products INC. $29.16 2022-2025 Acthar
Ani Pharmaceuticals, INC. $28.63 2025 Purified Cortrophin Gel
Inspire Medical Systems, INC. $23.71 2024 Inspire
Shionogi INC $23.20 2024 Fetroja
Grifols USA, LLC $22.20 2025 Prolastin-C Liquid
Resmed Corp $18.68 2022
Sunovion Pharmaceuticals INC. $17.63 2019
Fisher & Paykel Healthcare INC $16.10 2021
Axsome Therapeutics, INC. $15.69 2025 Sunosi
Teva Pharmaceuticals USA, INC. $13.74 2021
Tactile Systems Technology INC $12.92 2023 Flexitouch Plus, Entre Plus
Gilead Sciences, INC. $12.33 2021
Chiesi USA, INC. $12.21 2022
Pfizer INC. $11.97 2019
Melinta Therapeutics, LLC $11.95 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Carlos E Campo

$87,201.69

in general payments reported 2019-2025

Years
2019-2025
Top company
Boehringer Ingelheim Pharmaceuticals, INC.
Context
The $6,428 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/41210/carlos-e-campo

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.